Perimenopause is the transitional period leading up to menopause, characterized by fluctuating ovarian function and declining estrogen and progesterone production. These endocrine changes can precipitate sleep disruption and cognitive symptoms that many patients describe as “brain fog.” Understanding the bidirectional relationship between sex hormones, sleep architecture, and neurocognitive performance helps clinicians and patients target modifiable drivers rather than attributing symptoms solely to aging.
During perimenopause, irregular follicular activity produces unstable estradiol levels, often oscillating between relative surges and declines. This variability affects thermoregulation, circadian signaling, mood regulation, and neurotransmitter systems that directly influence sleep. A hallmark complaint is insomnia, which can manifest as trouble falling asleep, frequent awakenings, reduced total sleep time, and nonrestorative sleep. Night sweats and vasomotor symptoms (VMS) are common; they fragment sleep through abrupt increases in core body temperature and autonomic activation. Even when VMS are not prominent, hormonal fluctuations may alter sleep by changing gating of arousal systems and impacting slow-wave sleep stability.
Estrogen modulates multiple pathways relevant to sleep. It influences serotonergic and noradrenergic neurotransmission, which regulate sleep onset and maintenance, and it interacts with GABAergic signaling involved in inhibitory control of neuronal excitability. Progesterone and its metabolites act on the gamma-aminobutyric acid (GABA) receptor–mediated system, supporting sedation and sleep continuity. In perimenopause, the reduction and irregularity of progesterone exposure may reduce the normal “sleep-supportive” tone, making the nervous system more reactive during the night.
Circadian physiology also changes with age and endocrine transition. Estradiol interacts with clock genes in peripheral tissues and helps coordinate circadian rhythms. When estrogen levels become inconsistent, the timing of melatonin secretion and the amplitude of circadian rhythms may become less robust, promoting circadian misalignment. The result can include earlier awakenings, difficulty initiating sleep at desired times, and increased vulnerability to stress-induced insomnia.
Cognitive symptoms such as impaired attention, slower processing speed, and memory complaints are frequently reported during perimenopause. These may be driven by multiple mechanisms. First, chronic sleep fragmentation decreases hippocampal consolidation and impairs executive function networks, producing measurable deficits similar to those seen in other sleep disorders. Second, VMS and nocturnal awakenings increase nighttime sympathetic activity and inflammatory signaling, which can influence cognition through vascular and neuronal pathways. Third, fluctuating estrogen can modulate synaptic plasticity and cholinergic signaling, potentially contributing to cognitive inefficiency even in the absence of severe sleep loss.
Psychological factors commonly intersect with these biologic drivers. Perimenopause can coincide with stress, caregiving burdens, mood changes, and anxiety symptoms, which further amplify hyperarousal. Sleep restriction and cognitive preoccupation may create a reinforcing loop: hormonal symptoms disturb sleep, poor sleep worsens attention and mood, and anxiety about symptoms increases arousal, making sleep even harder to achieve.
Clinically, evaluation should distinguish primary insomnia from VMS-driven sleep disruption, mood disorders, sleep-disordered breathing, restless legs syndrome, and other contributors such as medication effects. A targeted history can clarify onset relative to menstrual pattern changes, severity of night sweats, and circadian timing. Screening for depression and anxiety is important, as is assessment of snoring, witnessed apneas, leg discomfort, caffeine/alcohol use, and thyroid symptoms. Tools such as sleep diaries and validated insomnia scales can quantify the sleep phenotype and guide treatment selection.
Treatment is most effective when tailored to the predominant driver. For VMS and sleep, menopausal hormone therapy may be considered for appropriate patients, typically balancing symptom severity, age, time since menopause onset, and cardiovascular risk. Alternatives can include nonhormonal approaches such as certain antidepressants, gabapentinoids, or other evidence-based therapies depending on contraindications and comorbidities. Behavioral interventions are foundational: cognitive behavioral therapy for insomnia (CBT-I) reduces insomnia severity and improves sleep efficiency, and it directly addresses maladaptive beliefs and behaviors that sustain hyperarousal.
Additionally, practical sleep strategies can reduce fragmentation: maintaining consistent wake times, limiting late-day caffeine and alcohol, optimizing bedroom temperature, and using cooling measures for nocturnal sweats. Relaxation training, stimulus control, and sleep restriction therapy (when appropriate under guidance) can restore sleep pressure dynamics. Patients should also be encouraged to address mental health symptoms and stress regulation, as treating anxiety and depressive symptoms can improve sleep and cognitive clarity.
Because cognitive complaints may reflect reversible sleep disruption, clinicians should counsel patients that “brain fog” can improve as sleep quality and symptom control improve. However, persistent or progressive cognitive impairment warrants further evaluation for neurologic or systemic causes. In summary, perimenopause can create a hormonal instability that perturbs thermoregulation, circadian coordination, and neurotransmitter balance, leading to insomnia and cognitive inefficiency. With careful assessment and integrated hormonal, behavioral, and symptomatic management, many patients experience meaningful improvement in both sleep and daytime cognitive function.
Source: [@RenaMalikMD]
Rena Malik, MD | Urologist: Ever feel like your mind’s foggy and sleep is a struggle? 🤔 It could be a hormonal roller coaster! Perimenopause can mess with sleep, impacting hormones and even cognitive function.. #breaking
— @RenaMalikMD May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
